Latest current assets for BFRIW: $13M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), BFRIW shows a current assets of $13M. That compares with $15M in the prior-year period — down 14.2% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, BFRIW's current assets is now $13M (was $15M) — a 14.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Biofrontera- Warrants (27/10/2026) is outperforming or lagging.
Tracking BFRIW's current assets over time shows whether Biofrontera- Warrants (27/10/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $13M That compares with $15M in the prior-year period — down 14.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current assets page, Stockcircle has Biofrontera- Warrants (27/10/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $13M) with ownership activity and broader fundamentals.
Biofrontera- Warrants (27/10/2026)'s current assets is $13M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.